Walgreens Boots Alliance, Inc. provides sales guidance for fiscal 2023. The company is raising full-year sales guidance to $133.5 billion to $137.5 billion reflecting Summit Health acquisition, refreshed currency rates, and first quarter sales ahead of expectations.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.91 USD | +1.53% | +4.97% | -54.73% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.73% | 10.13B | |
-44.50% | 8.54B | |
-19.34% | 6.49B | |
-3.00% | 6.29B | |
+92.00% | 5.25B | |
-2.48% | 4.61B | |
+6.16% | 4.55B | |
-31.43% | 3.72B | |
+6.00% | 3.1B | |
+156.94% | 2.5B |
- Stock Market
- Equities
- WBA Stock
- News Walgreens Boots Alliance, Inc.
- Walgreens Boots Alliance, Inc. Provides Sales Guidance for Fiscal 2023